Day: June 3, 2024

Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial

Written by Customer Service on . Posted in Public Companies.

The trial will be conducted in the U.S. and its results will complement the preclinical data on the LIBERTY® Endovascular Robotic Surgical System, which together are expected to support a future 510(k) submission BRAINTREE, Mass., June 03, 2024 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announces that it has received the U.S. Food and Drug Administration’s (“FDA”) approval to proceed with its pivotal human clinical trial as part of its Investigational Device Exemption (“IDE”) application for its LIBERTY® Endovascular Robotic Surgical System. The study will be conducted in the U.S., and the Company has already signed a clinical trial service agreement with a leading academic medical center. The Company is also in the process of engaging...

Continue reading

Kelly Completes Acquisition of Motion Recruitment Partners, LLC

Written by Customer Service on . Posted in Mergers And Acquisitions.

Transformational acquisition expected to accelerate EBITDA margin expansion MRP to continue delivering services through existing operating companies and brands Kelly management to host live webcast on June 18 to provide more details about the rationale for the acquisition and insights into MRP’s financial profile TROY, Mich., June 03, 2024 (GLOBE NEWSWIRE) — Kelly (Nasdaq: KELYA, KELYB) (“the Company”), a leading global specialty talent solutions provider, today announced it has completed the acquisition of Motion Recruitment Partners, LLC (“MRP”), from Littlejohn & Co., LLC (“Littlejohn”), a private investment firm based in Greenwich, Connecticut. Kelly previously announced on May 3, 2024, that it had entered into a definitive agreement to acquire MRP from Littlejohn. The acquisition of MRP strengthens the scale and capabilities...

Continue reading

Ex-dividend date of Enefit Green is 10 June 2024

Written by Customer Service on . Posted in Dividend Reports And Estimates.

Enefit Green (trading code EGR1T, ISIN code EE3100137985) will establish the list of shareholders entitled to receive dividend payment on 11 June 2024 at the end of the working day of the Nasdaq CSD settlement system (record date). Proceeding from the above, the ex-dividend date is 10 June 2024. From that date onwards the buyer of the shares is not entitled to receive dividends for the financial year 2023. Enefit Green will pay dividend €0.105 per share on 18 June 2024. Further information: Sven Kunsing Head of Finance Communication investor@enefitgreen.ee https://enefitgreen.ee/en/investorile/ Enefit Green is one of the leading renewable energy producers in the Baltic Sea area. The Company operates wind farms in Estonia and Lithuania, waste-to-energy CHP plant in Estonia, solar farms in Estonia and Poland and a hydroelectric plant in...

Continue reading

Evaxion Presents Positive and Validating Immune Data from Ongoing Phase 2 Trial with AI-Designed EVX-01 Vaccine at the ASCO Annual Meeting 2024

Written by Customer Service on . Posted in Public Companies.

Evaxion’s AI-designed cancer vaccine, EVX-01, triggered a specific and tumor-targeting immune response in all assayed melanoma patients Findings further confirm and validate the precision and predictive power of Evaxion’s AI vaccine target discovery and design platform, AI-Immunology™ COPENHAGEN, Denmark, June 03, 2024 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, reported data from its ongoing Phase 2 study at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024. The data demonstrated vaccine-induced immune response in metastatic melanoma patients treated with the Company’s AI-Immunology™ designed personalized cancer vaccine, EVX-01, in combination with an anti-PD1...

Continue reading

EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations

Written by Customer Service on . Posted in Public Companies.

New appointments bring significant commercial experience with a focus on growing key strategic markets Expands executive leadership in growing disruptive, robotics-based capital equipment in both Urology and Gynecology therapeutic applications LYON, France, June 3, 2024 – EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced the appointments of Damien Desmedt and Alexander Fromm to further strengthen the Company’s European and Middle Eastern commercial leadership. Mr. Desmedt has been appointed Vice President of Sales for Europe, Middle East, Africa, and India (EMEAI), and Mr. Fromm has been appointed General Manager for Switzerland and will oversee several strategic European territories. “We are pleased to announce the expansion of our international commercial leadership team with the...

Continue reading

Vaisala Corporation’s conveyance of treasury shares in accordance with share-based incentive plan

Written by Customer Service on . Posted in Public Companies.

Vaisala CorporationStock exchange releaseJune 3, 2024, at 3:00 p.m. (EEST) Vaisala Corporation’s conveyance of treasury shares in accordance with share-based incentive plan A total of 1,750 of Vaisala Corporation’s treasury shares have been conveyed without consideration to persons participating in the Restricted Share Unit Plan 2022–2026 under the terms and conditions of the plan. The directed share issue was based on an authorization given by the Annual General Meeting held on March 26, 2024. Following this directed share issue, the number of series A treasury shares is 137,378. Additional informationPaula Liimatta+358 9 8949 2020, ir@vaisala.com DistributionNasdaq Helsinki Key mediavaisala.com Vaisala is a global leader in measurement instruments and intelligence for climate action. We equip our customers with devices and data...

Continue reading

Apogee Minerals Announces Appointment of New Director

Written by Customer Service on . Posted in Public Companies.

Vancouver, British Columbia, June 03, 2024 (GLOBE NEWSWIRE) — Apogee Minerals Ltd. (“Apogee” or the “Company”) (TSXV: APMI) is pleased to announce the appointment of Mr. Nicholas Coltura as a Director of the Company. Mr. Coltura is a seasoned Investor Relations Manager specializing in the junior resource sector, working with different junior mining companies listed on the TSXV, CSE and OTC public markets. With several years of experience, Mr. Coltura has honed his expertise in communicating important public company information to a diverse range of investors and stakeholders. Throughout his career, Nicholas has been instrumental in building and maintaining strong relationships with investors and industry partners. His strategic approach to investor relations has successfully enhanced company visibility, fostered key relationships,...

Continue reading

Live Oak Bank Announces First Embedded Banking Partnership with Anatomy Financial, Inc.

Written by Customer Service on . Posted in Public Companies.

WILMINGTON, N.C., June 03, 2024 (GLOBE NEWSWIRE) — Live Oak Bank has announced its first embedded banking partnership with Anatomy Financial Inc., an AI-powered financial automation solution for medical, dental, digital health, and healthcare billing companies. Live Oak’s novel approach is the first of its kind, enabling software companies such as Anatomy to directly deliver Live Oak banking products and services to customers. The result is a collaboration where customers will receive best-in-class banking services conveniently embedded in the software they use the most. While these accounts are held at and serviced by Live Oak Bank, the product is exclusively available for customers on the Anatomy platform. “Our in-house technology and a next-generation Finxact core allow us to securely offer scalable banking services embedded...

Continue reading

aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”

Written by Customer Service on . Posted in Public Companies.

Ticker symbol change to take effect on Wednesday, June 5, 2024 SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the Company will be changing its ticker symbol from “LIFE” to “ATYR.” Effective at the market open on June 5, 2024, the Company’s common stock will trade on the Nasdaq Capital Market under the new symbol “ATYR.” “As we advance our lead therapeutic candidate, efzofitimod, through a pivotal Phase 3 study in pulmonary sarcoidosis and prepare for potential commercialization, the “ATYR” ticker symbol is a strong reflection of our corporate identity and serves to clarify and enhance our visibility...

Continue reading

Enphase Energy Launches IQ Battery 5P in Canada

Written by Customer Service on . Posted in Public Companies.

FREMONT, Calif., June 03, 2024 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world’s leading supplier of microinverter-based solar and battery systems, announced today that it started shipping its most powerful home battery to-date, the IQ® Battery 5P™, in Canada. The IQ Battery 5P is a modular design with 5 kWh capacity and can be paired with the new IQ8™ Microinverters to provide homeowners reliable electricity to use whenever they need it. The new Enphase® Energy System™ with the IQ Battery 5P enables configurations ranging from 5 to 80 kWh and offers a significantly improved experience for homeowners and installers because of more power, resilient wired communication, and an improved commissioning experience. Homeowners can also use the Enphase®...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.